Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. | J Pers Med | 2022 | 36013219 | PubTator, text mining | PubMed |
| Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2022 | 36011003 | PubTator, text mining | PubMed |
| Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance. | Cancers (Basel) | 2022 | 36010871 | PubTator, text mining | PubMed |
| Latency Trend Analysis as a Guide to Screening Malignancy Survivors for Second Primary Thyroid Cancer. | Biomedicines | 2022 | 36009531 | PubTator, text mining | PubMed |
| Signatures of adaptive evolution in platyrrhine primate genomes. | Proc Natl Acad Sci U S A | 2022 | 35994669 | PubTator, text mining | PubMed |
| Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells. | J Exp Clin Cancer Res | 2022 | 35989353 | PubTator, text mining | PubMed |
| Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage. | Cell Commun Signal | 2022 | 35986334 | PubTator, text mining | PubMed |
| In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases. | Eur J Pharmacol | 2022 | 35981605 | PubTator, text mining | PubMed |
| Chromosomal instability in adult-type diffuse gliomas. | Acta Neuropathol Commun | 2022 | 35978439 | PubTator, text mining | PubMed |
| Epigenetics, DNA damage, and aging. | J Clin Invest | 2022 | 35968782 | PubTator, text mining | PubMed |
| Breaking the aging epigenetic barrier. | Front Cell Dev Biol | 2022 | 35966762 | PubTator, text mining | PubMed |
| Bulk phase biochemistry of PIF1 and RecQ4 family helicases. | Methods Enzymol | 2022 | 35965006 | PubTator, text mining | PubMed |
| Replication dependent and independent mechanisms of GAA repeat instability. | DNA Repair (Amst) | 2022 | 35952488 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Unpaved roads: How the DNA damage response navigates endogenous genotoxins. | DNA Repair (Amst) | 2022 | 35939975 | PubTator, text mining | PubMed |
| Novel interaction interfaces mediate the interaction between the NEIL1 DNA glycosylase and mitochondrial transcription factor A. | Front Cell Dev Biol | 2022 | 35938152 | PubTator, text mining | PubMed |
| Human Variation in DNA Repair, Immune Function, and Cancer Risk. | Front Immunol | 2022 | 35935942 | PubTator, text mining | PubMed |
| A matter of delicate balance: Loss and gain of Cockayne syndrome proteins in premature aging and cancer. | Front Aging | 2022 | 35935726 | PubTator, text mining | PubMed |
| DNA fiber analyses to study functional importance of helicases and associated factors during replication stress. | Methods Enzymol | 2022 | 35934474 | PubTator, text mining | PubMed |
| To indel or not to indel: Factors influencing mutagenesis during chromosomal break end joining. | DNA Repair (Amst) | 2022 | 35926296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=26